Covered recipient · General Payments record
CRISTIN ANN WEICKER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$5,751.68
- Reported across 475 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $318.65 | 19 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $132.58 | 9 |
| PFIZER INC. | $124.13 | 7 |
| ABBVIE INC. | $45.04 | 2 |
| Amgen Inc. | $16.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $13.10 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999565409 | CMS |
| AbbVie Inc. | $31.94 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999565417 | CMS |
| Amgen Inc. | $16.90 | 10/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020558149 | CMS |
| Novo Nordisk Inc | $16.14 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542775 | CMS |
| Novo Nordisk Inc | $18.27 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542791 | CMS |
| Novo Nordisk Inc | $9.19 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542747 | CMS |
| Novo Nordisk Inc | $10.11 | 03/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542755 | CMS |
| Novo Nordisk Inc | $16.27 | 05/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542783 | CMS |
| Novo Nordisk Inc | $18.39 | 06/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542799 | CMS |
| Novo Nordisk Inc | $19.23 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542807 | CMS |
| Novo Nordisk Inc | $11.16 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542763 | CMS |
| Novo Nordisk Inc | $13.82 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000542767 | CMS |
| PFIZER INC. | $23.79 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050528839 | CMS |
| PFIZER INC. | $16.41 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050533409 | CMS |
| PFIZER INC. | $17.60 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050534505 | CMS |
| PFIZER INC. | $18.92 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049381970 | CMS |
| PFIZER INC. | $15.26 | 04/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049294969 | CMS |
| PFIZER INC. | $16.08 | 07/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050542725 | CMS |
| PFIZER INC. | $16.07 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050587381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.